Tag: Harvard

  • Alumni News: Winter 2024 | Harvard T.H. Chan School of Public Health

    Alumni News: Winter 2024 | Harvard T.H. Chan School of Public Health

    Marty Markay

    Harvard Chan alum Marty Makary chosen to lead FDA

    Martin “Marty” Makary, MPH ’98, will be nominated by President-elect Donald Trump to be commissioner of the Food and Drug Administration. If confirmed by the Senate, Makary would lead the agency responsible for regulating the nation’s food supply, vaccines, medicines and medical devices, cosmetics, tobacco, and biologics. Makary is a physician who specializes in surgical oncology and currently serves as chief of islet transplant surgery at the Johns Hopkins School of Medicine. He’s also a member of the National Academy of Medicine; a former leader of the World Health Organization Patient Safety Program; a medical and health policy researcher who has published more than 250 peer-reviewed articles; and an author who has written three New York Times best-selling books on health care. Read more

    Alumni win re-election to U.S., Iowa House seats

    Two alumni were re-elected to their seats in November: U.S. Rep. Raul Ruiz, MPH’07, of California’s District 25 and State Rep. Megan Srinivas, MPH ’15, of Iowa’s District 30.

    If you know of other alumni who ran in this election, please let us know.

    Epidemiology Alumni Q&A: Raymond Neutra
    Raymond Neutra, MPH ’69, DrPH ’74, has had a public health career in environmental medicine and epidemiology and has held leadership roles in academia and the public sector. Currently he is the president of the Neutra Institute for Survival Through Design, which promotes creative research and design that benefits people and the planet. He spoke with the Department of Epidemiology about his time as a graduate student and offered advice to current students.

    Disentangling complex medical outcomes

    Biostats alumna Linda Valeri, PhD ’13, was recently profiled  by Harvard Catalyst about the pilot funding that was critical to her research career. Valeri is an assistant professor in biostatistics at the Columbia University Mailman School of Public Health.

    Serving the community

    Deborah Cook Kaliel,SM ’06, recently spoke with The Amherst Student about her work with the U.S. Agency for International Development building sustainable HIV programs across the world.

    Alumni notes

    1980

    Jane Newburger, MPH, associate chair for academic affairs in the department of cardiology at Boston Children’s Hospital and Commonwealth Professor of Pediatrics at Harvard Medical School, received the 2024 Eugene Braunwald Academic Mentorship Award at the American Heart Association’s Scientific Sessions 2024 in November.

    1992

    Friday Okonofua, Takemi Fellow, was elected to the National Academy of Medicine in October. Okonofua is the leader of the Center of Excellence in Reproductive Health Innovation, University of Benin, in Nigeria. He has led research on maternal mortality prevention, with impact on policies and programming in African countries.

    1994

    Christine Sang, MPH, was named to the Clinical Advisory Board of Allay Therapeutics in October. She is associate professor of anesthesia at Harvard Medical School and the founding director of the Translational Pain Research program at Brigham and Women’s Hospital.

    1999

    Jessica Kahn, MPH, became the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research at Albert Einstein College of Medicine in October. She previously served as co-director of the Center for Clinical and Translational Science and Training and professor of pediatrics at the University of Cincinnati and as the founding associate chair of academic affairs and career development at Cincinnati Children’s.

    2002

    Lu Tian, SD, presented this year’s Lagakos Distinguished Alumni Award on “Adaptive Prediction Strategy with Individualized Variable Selection” in October. He is professor of biomedical data science at Harvard Medical School.

    2004

    Ashwin Vasan, SM, who led New York City through the COVID-19 pandemic as its 44th  Health Commissioner, was named the James McCune Smith Distinguished Fellow for the School of Global Health at Meharry Medical College in October.

    Kaja LeWinn, SM, SD ’07, professor of psychiatry and behavioral sciences at the University of California, San Francisco, received the Trinity College President’s Award for Science and Innovation in October. LeWinn’s research focuses on children’s neurodevelopment and mental health.

    2012

    Alisa Stephens-Shields,PhDassociate professor of biostatistics at the University of Pennsylvania Perelman School of Medicine, was the recipient of the 2024 Myrto Lefkopoulou Distinguished Lectureship in September. Stephens-Shields was recognized for her great capacity as both a methodologic and collaborative biostatistician and as a leader impacting health, statistical education, and inclusion in the field.

    2017

    Huda Zoghbi, SD, was invested as a member of the American Academy of Sciences and Letters in October. She is distinguished service professor at Baylor College of Medicine, an investigator with the Howard Hughes Medical Institute, and founding director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. 

    2021

    Irina Degtiar, PhD, received both the 2024 ASA Outstanding Statistical Application Award and the Manning Memorial Award for the Best Research in Health Econometrics for her dissertation paper. She currently is a statistician at Mathematica Research.

    2024

    Esias Bedingar, was selected to join WHO’s Global Action for Measurement of Adolescent Health (GAMA) Advisory Group. As a part of this 20-member group, he will help advise WHO and UN partners on research priorities and strategies to improve adolescent health measurement.

    Wedding

    Anup Kanodia, MPH ’08,married Rupal Ramesh Shah in June 2023 in Columbus, Ohio. Several Harvard Chan School classmates attended the ceremony, which incorporated America, Indian, and African traditions. Kanodia runs a medical practice in the Columbus area. See a photo feature on the wedding that ran in the Columbus Dispatch.

    In memoriam

    Evelyn Benson, MPH ’55, died on October 20 at 100. She was a rural public health nurse in Ohio and a community gerontological nurse in Chester, Penn. She later taught at Widener College and Temple University and was assistant dean of the School of Nursing at LaSalle University when she retired in 1994. She co-authored the textbook Community Health and Nursing Practice and wrote dozens of articles on public health nursing, international nursing, and nursing history. Read her obituary.

    Ralph Hoover, MPH ’62, died June 9 at 92. He was a physician and public health officer in Waterloo, Iowa, and in retirement went back to school to become a lawyer. He founded a law firm specializing in health care law. Read his obituary.

    David Wheeler, MPH ’09, died June 29 at 51. He was an internationally recognized biostatistician with a focus on spatial, cancer, and environmental epidemiology. He joined the Biostatistics Department at the School of Medicine at Virginia Commonwealth University in 2011 and was promoted to a full professorship in 2023. Read his obituary.

    DrPH alumni news

    Read alumni news from the DrPH program.

    Harvard Chan School alumni in action

    Tell us about your life since Harvard Chan School.


    Last Updated

    Get the latest public health news

    Stay connected with Harvard Chan School

    Source link

  • Harvard Chan School faculty recognized among world’s most influential researchers

    Harvard Chan School faculty recognized among world’s most influential researchers

    Exterior of Harvard T.H. Chan School of Public Health's Kresge building
    Harvard T.H. Chan School of Public Health’s Kresge building / Photo: Anna Webster

    More than 30 faculty members or researchers affiliated with Harvard T.H. Chan School of Public Health were named to Clarivate Analytic’s 2024 list of Highly Cited Researchers. The annual list includes researchers from around the world whose papers have been cited most often by their peers—in the top 1% of citations for a chosen field or fields.

    Worldwide, 6,886 researchers were named to the 2024 “highly cited” list. Those affiliated with Harvard Chan School are listed below. Thirteen Harvard Chan School faculty were identified as having exceptional performance across several fields. Their names are marked with an asterisk.

    They include: Rifat Atun*, Andrea Baccarelli*, David Bates*, Francesca Dominici*, Sarah Fortune*, Wendy Garrett, Edward Giovannucci, Christopher Golden*, William Hanage*, Miguel Hernan, Frank Hu, Curtis Huttenhower, Rafael Irizarry*, Ichiro Kawachi*, Karestan Koenen, Nancy Krieger, I-Min Lee, Marc Lipsitch*, Vasanti Malik*, Brendan Manning, JoAnn Manson, Vikram Patel, Alkes Price, Eric Rimm*, Shekhar Saxena, Meir Stampfer*, S.V. Subramanian, Elsie Sunderland, Tyler VanderWeele, Walter Willett, David Williams.

    Krieger was featured in a Q&A on the site as one of seven researchers whose work contributes to societal impact. She said, “As someone whose scientific work for health justice is not part of the mainstream research that dominates the public health and medical literature, I find it encouraging, from the standpoint of health equity, that my work is cited frequently enough to merit my being named a Highly Cited Researcher. It is an affirmation that my work is of use to others.”


    Last Updated

    Featured in this article

    Get the latest public health news

    Stay connected with Harvard Chan School

    Source link

  • Study opens door to a rethink of colonoscopy guidelines — Harvard Gazette

    Study opens door to a rethink of colonoscopy guidelines — Harvard Gazette


    A new analysis of nearly 200,000 adults shows that those with a clean result on their first colonoscopy may not need another for longer — perhaps significantly longer — than the current recommendation of 10 years.

    The result is a bit of good news about a cancer whose increasing rates in younger patients has worried experts, including the Harvard Chan School’s Mingyang Song, for several years. Colorectal cancer is the nation’s second-deadliest after lung cancer, killing an estimated 52,550 in 2023. While rates among older patients have been declining, younger patients — those 40 to 49 — have seen cases rise 15 percent between 2000 and 2026. Experts aren’t sure of the cause, but in 2021, the U.S. Preventive Services Task Force lowered the recommended age of first screening to 45 from 50. They also recommend that those with average risk get screened 10 years afterward.

    Song, an associate professor of clinical epidemiology and nutrition at the Chan School, said that the increase in screenings has also increased appointment wait times.

    “Especially with the lowered age, the clinic is overwhelmed,” said Song, also an associate professor at Harvard Medical School. “It was overwhelmed before, now it’s even worse.”

    In the work, published last month in JAMA Oncology, Song and colleagues examined colorectal cancer screening results and colorectal cancer incidence among 195,453 participants in three long-running studies: the Nurses’ Health Study, Nurses’ Health Study II, and the Health Professionals Followup Study. They compared incidence between two groups: those who received negative results in their initial colorectal cancer screening — meaning no polyps or cancer — and those who had not yet been screened.

    They found that the risk of developing colorectal cancer was significantly lower among those who had received a negative cancer screening than those who had not yet been screened. The research team, led by first author Markus Knudsen, a postdoctoral fellow in Song’s lab, then divided the negative screening result group according to lifestyle risk factors for colorectal cancer. The work was supported in part by the National Institutes of Health.

    The results showed that it took 16 years for those with a negative screening result and an intermediate-risk lifestyle to have the same colorectal cancer incidence of the unscreened group at 10 years. Those with negative screening and a low-risk lifestyle — including a healthy diet and exercise — didn’t reach the 10-year cancer incidence of the unscreened group until 25 years from their negative screening.

    The results, Song said, show that cancer screening should be individualized and discussed between patient and physician. While it is likely that additional evidence will be needed before national screening guidelines are changed, those with a negative screening result may be able to safely extend the screening interval beyond the recommended 10 years and, for those also living a low-risk lifestyle, perhaps as long as 20 years.

    What this more tailored approach would do, Song said, is spare those who might get little benefit from a colonoscopy while focusing increasingly scarce resources where they’re most needed: on people who’ve never been screened — only about 70 percent of eligible U.S. adults have been screened — on disadvantaged groups with historically lower screen rates, and on those whose lifestyle or family history puts them at increased risk.  

    “What we have seen generally is that the more advantaged groups of individuals are more likely to receive colonoscopy, whereas those who are disadvantaged and who actually have a higher risk of developing colon cancer are less likely to receive colonoscopy,” Song said. “We’ve tried to correct this mismatch and improve colonoscopy delivery at the population scale.”


    Source link